(Q35980619)

11 August 2017

1 reference

title

Pharmacogenetics in heart failure: genomic markers of endothelial and neurohumoral function (English)

1 reference

11 August 2017

0 references

1 reference

Dennis M McNamara

1

1 reference

11 August 2017

publication date

1 November 2004

1 reference

11 August 2017

published in

Congestive Heart Failure

1 reference

11 August 2017

volume

10

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

302-308

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

The bank robber Willie Sutton, author of Sutton's Law: "go where the money is." Famous phrases in radiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

Nitric oxide and cardiac function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1527-5299.2004.03855.X

10.1111/J.1527-5299.2004.03855.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference